Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi (Q56828549)

1

0 references

Shajahan Abdu

2

0 references

Brian Godman

3

0 references

Sahar Fahmy

4

0 references

Rickard E Malmström

Expert Review of Pharmacoeconomics & Outcomes Research

5

0 references

publication date

February 2012

0 references

published in

0 references

volume

12

0 references

issue

1

0 references

page(s)

115-124

0 references

cites work

Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction

1 reference

Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

21 January 2018

1 reference

Insight into recent reforms and initiatives in Austria: implications for key stakeholders

21 January 2018

1 reference

Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications

21 January 2018

1 reference

Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.

21 January 2018

1 reference

Policies to enhance prescribing efficiency in europe: findings and future implications

21 January 2018

1 reference

Initiatives to enhance renin-angiotensin prescribing efficiency in Austria: impact and implications for other countries

21 January 2018

1 reference

Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance

21 January 2018

1 reference

The ‘Wise List’- A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm

21 January 2018

1 reference

Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment

21 January 2018

1 reference

Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs

21 January 2018

1 reference

Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future

21 January 2018

1 reference

Switching statins in Norway after new reimbursement policy: a nationwide prescription study

21 January 2018

1 reference

Impact of restricted reimbursement on the use of statins in Finland: a register-based study

21 January 2018

1 reference

Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences

21 January 2018

1 reference

Influence of demand-side measures to enhance renin-angiotensin prescribing efficiency in Europe: implications for the future

21 January 2018

1 reference

Different versions of the anatomical therapeutic chemical classification system and the defined daily dose--are drug utilisation data comparable?

21 January 2018

1 reference

Coping with changes in the Defined Daily Dose in a longitudinal drug consumption database

21 January 2018

1 reference

Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications

21 January 2018

1 reference

Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs

21 January 2018

1 reference

Balancing Big Pharma's books

21 January 2018

1 reference

Evaluation of drug use practices at primary healthcare centers of Kuwait

21 January 2018

1 reference

A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.

21 January 2018

1 reference

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

21 January 2018

1 reference

Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.

21 January 2018

1 reference

Having your cake and eating it: office of fair trading proposal for funding new drugs to benefit patients and innovative companies

21 January 2018

1 reference

Potential savings without compromising the quality of care

21 January 2018

1 reference

Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on.

21 January 2018

1 reference

Pay-for-performance programs in family practices in the United Kingdom

21 January 2018

1 reference

Enhancing the rational use of new medicines across European health care systems

21 January 2018

1 reference

The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review

21 January 2018

1 reference

21 January 2018

Using clinical evidence

1 reference

From best evidence to best practice: effective implementation of change in patients' care

21 January 2018

1 reference

Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group

21 January 2018

1 reference

Long-term proton pump inhibitor therapy and risk of hip fracture

21 January 2018

1 reference

Systematic review of the risk of enteric infection in patients taking acid suppression

21 January 2018

1 reference

Overprescribing proton pump inhibitors

21 January 2018

1 reference

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection

21 January 2018

1 reference